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As the open access movement begins revolutionizing the
publication of publicly funded biomedical research, it is
time to ensure access to important scientific discoveries
and opinions within and across the disciplines which
have direct bearing on health and quality of life in
resource poor settings and in countries of the world where
library budgets are seriously shrinking. In this concern,
the area of enteric infectious diseases and gut health has
been of paramount significance. For example, the enteric
infections that cause diarrhoeal diseases already consti-
tute one of the top 10 causes of death and kill approxi-
mately 1.81 million people in the developing world
(6.9% of total deaths), a figure which is more dramatic
and alarming than the number of deaths associated with
tuberculosis and malaria put together (Source: The WHO)
[1].
To this end, the International Society for Genomic and
Evolutionary Microbiology (ISOGEM) in collaboration
with BioMed Central Ltd. has launched Gut Pathogens with
the aim of providing a high-quality forum for research on
enteric infections of humans and animals. The journal led
by three Editors-in-Chief and supported by a highly qual-
ified and organized international Editorial Board [2] pub-
lishes open access research articles of repute in areas of
biology and the pathogenesis of bacterial, parasitic and
viral infections of the gut including their diagnosis, epide-
miology and clinical management.
Besides publication of peer-reviewed research articles and
case reports, Gut Pathogens is also mandated to publish
scholarly reviews and other opinionated articles related to
microbial etiology of gut ailments; microbial invasion
mechanisms; bacterial toxins and virulence factors of the
pathogens of gut and associated glands (liver, pancreas);
bacterial adaptation and evolution of pathogenicity;
molecular and serological diagnoses; treatment, vaccines
and antimicrobial resistance mechanisms; molecular epi-
demiology, transmission dynamics and evolutionary
genetics and comparative and veterinary infectious dis-
eases of the gut.
The field of medical microbiology has expanded tremen-
dously in the aftermath of genomic revolution [3], and
microbial organisms in the gut have already taken center
stage among all other microbiota of the human surfaces
[4-6]. Metagenomics and systems biology approaches
[4,5] have enabled new insights [6] into the complex
existence of the gut ecosystem and hold tremendous
potential to boost our understanding of the elements of
host-microbial co-evolution, commensalism versus para-
sitic invasions and the boundaries thereof. In view of such
an exciting and fast-moving scenario, there is a clear
opportunity for Gut Pathogens to be seen also as a timely
initiative to serve communities associated with a) biology
and ecology of gut pathogens, the commensals and the
probiotic species [7,8] in health and disease, b) host sus-
ceptibility or resistance to such organisms, c) immune
reactions of gut infections and d) the triggers of autoim-
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munity in inflammatory bowel diseases [9,10] and other
metabolic syndromes [11,12].
As like all BioMed Central journals, Gut Pathogens shall be
committed to the open access publication policy – the
concept that has revolutionized research access to com-
munities and that was recently endorsed by major fund-
ing agencies including the NIH and the Wellcome Trust.
In addition to its embracement of open access, Gut Patho-
gens shall also aim to support the concept of Science 2.0
[13] by providing a truly open platform for discussions,
commenting and rating of the subjective impact of indi-
vidual articles.
In the near future, medical and biosciences communities
will need to possibly consider novel findings and para-
digms that are emerging in the aftermath of genome
sequencing and metagenomics of the gut microorgan-
isms. Also, those who diagnose and treat patients with
enteric disorders will need to understand the nature and
complexities of the interactions of the so called 'invaders'
[14] with our intestinal ecosystem in health, and their per-
turbations in disease, and the roles and contribution of
our gut symbionts and commensals in guarding and
ensuring normalcy of the gut or otherwise. This shall
greatly facilitate the practice of preventive and social med-
icine in a most effective and pertinent manner. Gut Patho-
gens will always strive to assist scientists and clinicians in
this endeavor by translating the most recent advances for
the benefit of patients.
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